- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/50 - Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Patent holdings for IPC class G01N 33/50
Total number of patents in this class: 22671
10-year publication summary
1622
|
1628
|
1913
|
1972
|
1963
|
1844
|
1660
|
1634
|
1385
|
397
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 18943 |
355 |
President and Fellows of Harvard College | 5792 |
237 |
Massachusetts Institute of Technology | 9795 |
180 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
180 |
Dana-Farber Cancer Institute, Inc. | 2455 |
168 |
The Johns Hopkins University | 5377 |
159 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
142 |
Centre National de La Recherche Scientifique | 9632 |
138 |
The General Hospital Corporation | 4517 |
137 |
F. Hoffmann-La Roche AG | 7958 |
126 |
Osaka University | 3143 |
119 |
The University of Tokyo | 3903 |
117 |
Immatics Biotechnologies GmbH | 1144 |
115 |
Kyoto University | 2732 |
112 |
Regeneron Pharmaceuticals, Inc. | 3650 |
104 |
Institut National de La Sante et de La Recherche Medicale (inserm) | 2360 |
99 |
Board of Regents, The University of Texas System | 5370 |
87 |
Genentech, Inc. | 3742 |
86 |
The Broad Institute, Inc. | 1584 |
84 |
The Brigham and Women's Hospital, Inc. | 2087 |
83 |
Other owners | 19843 |